Rights and permissions
About this article
Cite this article
Roche/Pharmac agreement sees rituximab, PEG IFN funded in NZ. Pharmacoecon. Outcomes News 446, 11 (2004). https://doi.org/10.2165/00151234-200404460-00031
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404460-00031